ArticleBMC medicine2026
Immune cell subsets linking insomnia trajectories and incident cognitive impairment: a prospective cohort study.
Article in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
backgroundThis study aimed to examine the associations between insomnia trajectories and the risk of incident cognitive impairment, as well as to evaluate whether immune cell subsets mediate these associations.
methodsA total of 6,316 participants aged 50 years or older from the Health and Retirement Study (HRS) were included in this prospective cohort study. Insomnia symptoms, including severe insomnia, difficulty initiating sleep (DIS), difficulty maintaining sleep (DMS), early morning awakening (EMA), and nonrestorative sleep (NRS), were assessed using the Jenkins Sleep Questionnaire. Longitudinal insomnia trajectories were identified from three examination waves during 2010-2016 (waves 10, 12 and 13) using latent class trajectory modeling. Incident cognitive impairment was defined according to the Langa-Weir cognitive status classification during 2016-2022 (waves 13-16). Data on immune cell subsets were obtained through flow cytometry of peripheral blood samples collected in the 2016 HRS Venous Blood Substudy. Cox proportional hazards models and mediation analyses were performed to assess associations.
resultsTrajectories of DIS, EMA, and NRS were significantly associated with increased risk of incident cognitive impairment. Compared to participants with persistently good trajectories, those with worsening trajectories demonstrated significantly elevated risks of cognitive impairment, with hazard ratios of 1.37 (95% confidence interval [CI]: 1.16, 1.61) for DIS; 1.26 (95% CI: 1.07, 1.48) for EMA; and 1.16 (95% CI: 1.00, 1.35) for NRS. Mediation analysis revealed seven specific immune cell subsets as mediators of the associations of insomnia trajectories (DIS, EMA, and NRS) with the risk of incident cognitive impairment: CD4 + T cells (central memory, CM), CD4 + T cells (Naive), CD4 + T cells (Effector Memory, Tem), CD8 + T cells, CD8 + T cells (CM), CD8 + T cells (TemRA) and NK Cells (CD56LO), accounting for 1.16% to 8.21% of the total effect. Sex-stratified analysis revealed distinct mediation patterns: CD4 + T cells (Tem) and CD8 + T cells mediated the associations in males, whereas CD4 + T cells (CM), CD8 + T cells (CM) mediated the associations in females.
conclusionsThese findings reveal the associations of dynamic insomnia trajectories with cognitive health, and potential immune mechanisms, suggesting that maintaining healthy sleep patterns may mitigate neurodegenerative progression.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.